Gearing up for genome-wide gene-association studies
1Department of Cardiovascular Medicine, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK and 2Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
* To whom correspondence should be addressed at: Department of Cardiovascular Medicine, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford, OX3 7BN, UK. Email: martin.farrall{at}well.ox.ac.uk
Received July 6, 2005; Accepted July 22, 2005
One of the grand challenges of human genetics to systematically map by gene-association susceptibility genes for complex diseases is underway. High-throughput genotyping platforms have been developed; a comprehensive map of human genetic variation (HapMap) to guide efficient marker selection is imminent and many researchers have assembled suitable cohorts of patients. Expectations are understandably high and it is timely to review the promise and pitfalls of this strategy.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Takabatake, H. Ishihara, Y. Ohmachi, I. Tanaka, M. M. Nakamura, K. Fujikawa, T. Hirouchi, S. Kakinuma, Y. Shimada, Y. Oghiso, et al. Microarray-based global mapping of integration sites for the retrotransposon, intracisternal A-particle, in the mouse genome Nucleic Acids Res., June 1, 2008; 36(10): e59 - e59. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Khoury, J. Little, M. Gwinn, and J. P. Ioannidis On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies Int. J. Epidemiol., April 1, 2007; 36(2): 439 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Thomas Are We Ready for Genome-wide Association Studies? Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 595 - 598. [Full Text] [PDF] |
||||


